Vedanta Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
9
- Investments
-
44
- Portfolio
-
7
- Exits
-
29
Vedanta Capital General Information
Company Description
Founded in 2006, Vedanta Capital is a venture capital firm based in New York. The firm seeks to invest in B2C, healthcare, information technology, foodtech, SaaS, TMT, lifesciences, pet technology, retail and beauty sectors.
Business Details
Website
www.vedacap.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 250 West 55th Street
- Suite 16C
- New York, NY 10019
- United States
Vedanta Capital Investments (44)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Bicara Therapeutics | 06-Dec-2023 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| Bicara Therapeutics | 08-Sep-2023 | Drug Discovery | Generating Revenue | |||
| Immuneel | 11-Apr-2022 | Drug Discovery | Clinical Trials - General | |||
| TauC3 Biologics | 31-Mar-2022 | Drug Discovery | Pre-Clinical Trials | |||
| Eruditus Executive Education | 31-Aug-2020 | Education and Training Services (B2B) | Profitable | |||
| Immuneel | 10-Aug-2020 | Drug Discovery | Clinical Trials - General | |||
| Volterra. | 07-Nov-2019 | Systems and Information Management | Generating Revenue | |||
| SetuServ | 04-Oct-2018 | Business/Productivity Software | Generating Revenue | |||
| Oncternal Therapeutics | 15-Dec-2017 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| Breathe Technologies | 29-Mar-2017 | Later Stage VC | Therapeutic Devices | Profitable |
Vedanta Capital Exits (29)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| d2i | 07-Apr-2026 | Buyout/LBO | |
| Bicara Therapeutics | 13-Sep-2024 | ||
| Chelsio Communications | 01-May-2023 | ||
| Volterra. | 22-Jan-2021 | ||
| Augere | 01-Oct-2019 | ||
| Breathe Technologies | 03-Sep-2019 | ||
| Oncternal Therapeutics | 07-Jun-2019 | ||
| Callidus Software | 05-Apr-2018 | ||
| Azoi | 01-Nov-2017 | Out of Business | |
| Genband | 27-Oct-2017 | Merger/Acquisition |
Vedanta Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Vedanta Capital Investments by Industry, Year, and Region
Vedanta Capital Co-Investors (30)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Eight Roads | 2 |
|
|
||
| F-Prime |
|
|
|||
| Fairmount Partners |
|
|
|||
| Piper Sandler |
|
|
|||
| TPG |
|
|
Vedanta Capital FAQs
-
What is Vedanta Capital?
Founded in 2006, Vedanta Capital is a venture capital firm based in New York.
-
When was Vedanta Capital founded?
Vedanta Capital was founded in 2006.
-
Where is Vedanta Capital headquartered?
Vedanta Capital is headquartered in New York, NY.
-
What is Vedanta Capital's total asset value?
Vedanta Capital has around in total assets under management.
-
How many investments has Vedanta Capital made?
Vedanta Capital has made 44 investments.
-
What has Vedanta Capital invested in?
Vedanta Capital has made numerous investments in companies like Bicara Therapeutics, Immuneel, and TauC3 Biologics within the Drug Discovery industry.
-
What has Vedanta Capital invested in recently?
Vedanta Capital's latest investment was on 06-Dec-2023 in Bicara Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process